Can We Really Cheat Death? The Science of Living Beyond 122
What if living past 122 isn’t just a dream — but a dangerous obsession?
The quest for extended life is no longer confined to science fiction; it’s a burgeoning industry fueled by scientific breakthroughs, public interest, and significant investment. From cellular reprogramming to senolytics, researchers are exploring various avenues to slow aging and extend human life.
However, despite the promise, the complexity of aging biology means success is far from guaranteed. Some therapies, like those targeting senescent cells, have shown promise in animal studies but failed in human trials. Meanwhile, the X Prize is offering $101 million for a treatment that can add a decade of healthy life to older adults — an ambitious goal that reflects both the potential and uncertainty in the field.
As the longevity industry pushes boundaries, we must ask: Is the pursuit of extreme life extension a path to better health, or are we venturing into uncharted and potentially perilous territory?
Read the full article on MIT Technology Review.
----
💡 If you enjoyed this content, be sure to download my new app for a unique experience beyond your traditional newsletter.
This is one of many short posts I share daily on my app, and you can have real-time insights, recommendations and conversations with my digital twin via text, audio or video in 28 languages! Go to my PWA at app.thedigitalspeaker.com and sign up to take our connection to the next level! 🚀